Susquehanna Fundamental Investments’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $96.7K | Sell |
67,617
-144,386
| -68% | -$206K | ﹤0.01% | 698 |
|
|
2025
Q1 | $339K | Buy |
212,003
+103,339
| +95% | +$165K | ﹤0.01% | 930 |
|
|
2024
Q4 | $391K | Buy |
+108,664
| New | +$391K | 0.01% | 899 |
|
|
2024
Q2 | $600K | Buy |
129,801
+78,436
| +153% | +$362K | 0.01% | 650 |
|
|
2024
Q1 | $420K | Buy |
+51,365
| New | +$420K | 0.02% | 498 |
|
|
2023
Q4 | – | Sell |
-17,572
| Closed | -$32.7K | – | 115 |
|
|
2023
Q3 | $32.7K | Hold |
17,572
| – | – | ﹤0.01% | 355 |
|
|
2023
Q2 | $48.3K | Hold |
17,572
| – | – | ﹤0.01% | 623 |
|
|
2023
Q1 | $55.2K | Sell |
17,572
-14,924
| -46% | -$46.9K | ﹤0.01% | 922 |
|
|
2022
Q4 | $192K | Buy |
+32,496
| New | +$192K | ﹤0.01% | 1074 |
|